Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Co-dydramol (Dihydrocodeine/paracetamol)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Co-dydramol 10mg/500mg tablets
0407010N0AAAAAA
|
Co-dydramol | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | 157,795 |
|
Co-dydramol 30mg/500mg tablets
0407010N0AAAIAI
|
Co-dydramol | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | 15,909 |
|
Co-dydramol 20mg/500mg tablets
0407010N0AAAHAH
|
Co-dydramol | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | 13,042 |
|
Remedeine Forte tablets
0407010N0BGABAI
|
Remedeine | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | 4,475 |
|
Remedeine tablets
0407010N0BGAAAH
|
Remedeine | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | 3,227 |
|
Eroset 500mg/10mg tablets
0407010N0BIAAAA
|
Eroset | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | 37 |
|
Co-dydramol 10mg/500mg/5ml oral suspension
0407010N0AAAGAG
|
Co-dydramol | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | 19 |
|
Co-dydramol 10mg/500mg/5ml oral solution
0407010N0AAACAC
|
Co-dydramol | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | 9 |
|
Co-dydramol 7.46mg/500mg tablets
0407010N0AAAJAJ
|
Co-dydramol | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | 2 |
|
Co-dydramol 10mg/500mg oral powder sachets
0407010N0AAAFAF
|
Co-dydramol | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | No data available |
|
Co-dydramol 7.46mg/500mg effervescent tablets sugar free
0407010N0AAAKAK
|
Co-dydramol | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | No data available |
|
Dental Pain Relief tablets
0407010N0BEABAJ
|
Boots (co-dydramol) | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | No data available |
|
Dypracet 20mg/500mg tablets
0407010N0BFAAAH
|
Dypracet | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | No data available |
|
Dypracet 30mg/500mg tablets
0407010N0BFABAI
|
Dypracet | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | No data available |
|
Galake 10mg/500mg tablets
0407010N0BCAAAA
|
Galake | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | No data available |
|
Paramol soluble tablets
0407010N0BHACAK
|
Paramol | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | No data available |
|
Paramol tablets
0407010N0BHABAJ
|
Paramol | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.